Search details
1.
Plasma IL-2 and Symptoms Response after Acute Gluten Exposure in Subjects With Celiac Disease or Nonceliac Gluten Sensitivity.
Am J Gastroenterol
; 117(2): 319-326, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34797778
2.
A retro-inverso α-melanocyte stimulating hormone analog with MC1R-binding selectivity.
J Pept Sci
; 17(1): 47-55, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-21171144
3.
A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease.
Front Immunol
; 12: 661622, 2021.
Article
in English
| MEDLINE | ID: mdl-34093551
4.
Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity.
United European Gastroenterol J
; 8(1): 108-118, 2020 02.
Article
in English
| MEDLINE | ID: mdl-32213060
5.
Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease.
Aliment Pharmacol Ther
; 50(8): 901-910, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31483515
6.
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease.
Sci Adv
; 5(8): eaaw7756, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31457091
7.
Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
EBioMedicine
; 26: 78-90, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-29191561
8.
Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.
Lancet Gastroenterol Hepatol
; 2(7): 479-493, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28506538
9.
Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion.
Transplantation
; 87(7): 966-74, 2009 Apr 15.
Article
in English
| MEDLINE | ID: mdl-19352114
10.
Characterization of the peptide-binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from simian immunodeficiency virus proteins.
J Immunol
; 169(1): 210-9, 2002 Jul 01.
Article
in English
| MEDLINE | ID: mdl-12077247
11.
Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution.
Immunogenetics
; 54(12): 830-41, 2003 Mar.
Article
in English
| MEDLINE | ID: mdl-12671733
12.
Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection
Medicina (B.Aires)
; 57(Suppl.2): 34-42, Aug. 1997.
Article
in Spanish
| LILACS, BINACIS | ID: biblio-1165035
13.
Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection
Medicina [B.Aires]
; 57(Suppl.2): 34-42, Aug. 1997.
Article
in English
| BINACIS | ID: bin-7444
14.
Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection
Medicina (B.Aires)
; 57(Supl.2): 34-42, Aug. 1997.
Article
in English
| LILACS | ID: lil-320010
Results
1 -
14
de 14
1
Next >
>>